Chemotherapy Drug Handling SWMS
Cytotoxic drug preparation and administration — Class II Type B biological safety cabinet operation, closed-system transfer device use, spill-response kit deployment, linen and sharps segregation, pregnant-worker reassignment protocol.
SWMS variants reference your state’s WHS legislation. Instant download after payment.
Chemotherapy drug handling covers the preparation, transport, administration and disposal of cytotoxic and reproductive-toxin medicines within hospital pharmacy cleanrooms, oncology day-units and inpatient wards. The work involves manipulating Class 6.1 hazardous chemicals inside Class II Type B2 biological safety cabinets, deploying closed-system transfer devices (CSTDs), managing patient excreta for up to seven days post-dose, and responding to spills of genotoxic agents. Under Model WHS Regulation 2025 Part 7.1 (Hazardous Chemicals) and Schedule 1 Category 10, any task involving carcinogenic, mutagenic or reproductive-toxin substances is High-Risk Construction/Health Work requiring a documented Safe Work Method Statement before work commences. The SWMS is mandatory because cytotoxics present chronic occupational exposure risks — including secondary cancers, foetal harm and chromosomal damage — that cannot be controlled through PPE alone and demand engineered containment, validated procedures and worker consultation evidenced in writing. This document satisfies the PCBU duty under s19 of the WHS Act and the chemical-specific control duties in regs 354–378.
Hazards identified
7 hazards covered, sorted by priority.
Inhalation of genotoxic aerosols causing chromosomal damage, secondary leukaemia and demonstrable urinary metabolite contamination in unprotected staff
Dermal absorption causing local necrosis, sensitisation dermatitis and systemic genotoxic exposure measurable through biomonitoring
Direct inoculation of cytotoxic agent causing severe tissue necrosis, extravasation injury and bloodborne pathogen co-exposure requiring surgical intervention
Teratogenic effects, spontaneous abortion and low birth weight documented in nurses with ongoing first-trimester cytotoxic handling exposure
Loss of operator protection envelope releasing cytotoxic aerosols into pharmacy cleanroom, contaminating staff, surfaces and adjacent product preparations
Wide-area contamination, evacuation of clinical zone, regulatory notification and potential serious-incident reporting under WHS Act s38
Secondary exposure of cleaning staff, laundry workers and family members through unrecognised contact with bodily fluids containing active metabolites
Control measures
Hierarchy-of-controls order: elimination → substitution → isolation → engineering → administrative → PPE.
- 1Elimination — Substitute oral or pre-prepared dose-banded products supplied by licensed compounding facilities to remove the need for ward-level reconstitution wherever clinically appropriate.
- 2Elimination — Reassign pregnant, breastfeeding or actively conceiving workers away from all cytotoxic preparation, administration and waste-handling duties for the declared period under SHPA Guidelines section 4.6.
- 3Substitution — Procure ready-to-administer infusion bags from a TGA-licensed manufacturing pharmacy in preference to in-house reconstitution to reduce manipulation steps and aerosol generation potential.
- 4Substitution — Replace open-system luer connectors with closed-system transfer devices (CSTDs) validated to ISO 14644 and tested for vapour containment per NIOSH protocol.
- 5Engineering — Prepare all cytotoxics inside a Class II Type B2 Biological Safety Cabinet compliant with AS 2252.4 and AS/NZS 2567, certified six-monthly with documented airflow verification.
- 6Engineering — Operate cleanroom at negative pressure relative to anteroom with minimum 12 air changes per hour and HEPA-filtered exhaust ducted externally per PIC/S PE009 Annex 1.
- 7Administrative — Maintain a chemotherapy competency register requiring annual reaccreditation, validated aseptic technique broth fills and documented training on spill-kit deployment under SHPA guidance.
- 8Administrative — Display CSTD assembly sequence, BSC cleaning protocol and spill-response flowchart at point of use and verify pre-start sign-on against this SWMS for every preparation session.
- 9PPE — Wear double chemotherapy-rated nitrile gloves (ASTM D6978), impervious long-sleeve gown, N95 respirator and full face-shield during all manipulation, changing outer glove every 30 minutes.
- 10PPE — Don supplied-air respiratory protection meeting AS/NZS 1716 when responding to spills exceeding 50 mL or any BSC containment breach prior to decontamination.
Applicable Codes of Practice
Imposes duties to assess, label, register and control cytotoxic chemicals; reg 357 mandates manifest, reg 361 requires health monitoring for genotoxic exposures.
Specifies Class II Type B2 cabinet construction, airflow verification, six-monthly certification and operator protection factor testing required before any cytotoxic preparation.
Establishes pregnant-worker reassignment, CSTD use, double-gloving and seven-day excreta precautions referenced as accepted industry practice under WHS Act s19.
Provides the hierarchy-of-control framework, SDS interpretation duties and emergency planning obligations for Schedule 10 prohibited and restricted carcinogens.
High-Risk Construction Work triggered
Cytotoxic drugs are GHS Category 1A/1B carcinogens, mutagens and reproductive toxins, meeting the Schedule 1 threshold for hazardous chemical high-risk work regardless of quantity handled.
PCBUs must prepare and consult workers on this SWMS before work starts, monitor compliance, revise on change, and retain records for two years after work ceases or until any notifiable incident is resolved. Penalties for failure are substantial and indexed; the current maximum follows the prevailing WHS schedule.
Who this is for
- →Hospital pharmacy compounding technicians and aseptic services pharmacists
- →Oncology and haematology day-unit registered nurses
- →Infection control and WHS coordinators in tertiary public hospitals
- →Environmental services and laundry supervisors handling cytotoxic waste streams
What you receive
- ✓Editable DOCX template — Microsoft Word compatible
- ✓State-specific WHS legislation schedule (NSW/VIC/QLD/SA/WA/TAS/NT/ACT)
- ✓Hazard register with risk ratings + hierarchy-of-control mapping
- ✓Worker sign-on register, pre-start checklist, and incident escalation flow
Worked example
At a 600-bed metropolitan tertiary hospital oncology day-unit, the nurse unit manager runs the 0730 pre-start huddle before the day's 28 scheduled infusions. She opens the Chemotherapy Drug Handling SWMS on the shared tablet and walks the four-nurse team through the hazard register, pausing on aerosol generation and needlestick risks because today's list includes three high-volume cyclophosphamide doses. Two nurses confirm their CSTD competency dates are current; a third declares an early pregnancy and is reassigned under the SWMS pregnant-worker protocol to non-cytotoxic patient education for the shift, with the reassignment logged on the sign-on sheet. The team verifies the spill kit seal, confirms the BSC certification sticker is in date (last certified six weeks ago against AS/NZS 2567), and reviews the double-glove change-out interval. Mid-morning, a CSTD vial spike resists seating and the senior nurse pauses preparation, references the SWMS containment-failure control step, isolates the partially prepared dose in a sealed cytotoxic bag, and contacts pharmacy for a replacement vial rather than forcing the connection. The deviation, the corrective action and the worker who made the call are recorded against the SWMS as a dynamic risk review. At shift end the sign-off sheet, deviation note and competency confirmations are filed in the unit's WHS folder for the regulated two-year retention period.
Related legislation
- WHS Act 2011 (model)
- WHS Regulation 2025
- Code of Practice — Hazardous Manual Tasks